Skip to main content
Clinical Trials/NCT05577039
NCT05577039
Completed
Not Applicable

Preoperative Renal Resistive Index to Predict Long-term Development of Chronic Kidney Disease in Patients Undergoing Cardiac Surgery

Region Stockholm1 site in 1 country96 target enrollmentNovember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
Region Stockholm
Enrollment
96
Locations
1
Primary Endpoint
Long-term renal dysfunction
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Renal resistive index (RRI) is calculated from ultrasonographic Doppler measurements of flow velocities in intraparenchymal renal arteries. Normal values are around 0.60, and 0.70 is considered the upper normal threshold in adults. Both preoperative and postoperative elevation of RRI has shown promise in early detection of AKI after cardiac surgery. Further, elevated RRI before coronary angiography is associated with an increased risk of cardiovascular complications up to 1 year after the procedure. The role of preoperative RRI in predicting long-term renal and cardiovascular complications after elective surgery is however not known. The aim of this study is to assess the role of preoperative RRI to predict the risk of persistent renal dysfunction as well as renal- and cardiovascular complications up to 5 years after surgery.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
September 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Elective coronary artery bypass grafting, heart valve surgery, or aortic surgery performed at Karolinska University Hospital between September 2014 and April 2015
  • Preoperative measurement of RRI performed with satisfactory Doppler reading
  • Written informed consent

Exclusion Criteria

  • Kidney transplant
  • Dialysis-dependent kidney disease
  • Cancelled surgery
  • Missing follow-up data

Outcomes

Primary Outcomes

Long-term renal dysfunction

Time Frame: 5 years after surgery or end of follow-up

Reduced estimated glomerular filtration rate (eGFR) ≥25% from baseline

Secondary Outcomes

  • Major adverse cardiac and cerebrovascular events (MACCE)(30 days, 90 days, 1 year, and 5 years after surgery or end of follow-up)
  • Intermediate renal dysfunction(90 days after surgery)
  • Major adverse kidney events (MAKE)(30 days, 90 days, 1 year, and 5 years after surgery or end of follow-up)
  • Short-term renal dysfunction(30 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials